ProShare Advisors LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$43,000
-46.2%
14,375
-19.1%
0.00%
Q4 2021$80,0000.0%17,758
+7.5%
0.00%
Q3 2021$80,000
-42.4%
16,524
-18.6%
0.00%
Q2 2021$139,000
+9.4%
20,308
+13.0%
0.00%
Q1 2021$127,000
+21.0%
17,971
+7.6%
0.00%
Q4 2020$105,000
+94.4%
16,707
+34.1%
0.00%
Q3 2019$54,000
+5.9%
12,454
-3.2%
0.00%
Q2 2019$51,000
-33.8%
12,870
-10.7%
0.00%
Q1 2019$77,000
+5.5%
14,417
+1.4%
0.00%
-100.0%
Q4 2018$73,000
-55.2%
14,212
-15.4%
0.00%0.0%
Q3 2018$163,000
-8.4%
16,791
-3.6%
0.00%0.0%
Q2 2018$178,000
-23.3%
17,424
-2.4%
0.00%
-50.0%
Q1 2018$232,000
-30.3%
17,857
-3.9%
0.00%0.0%
Q4 2017$333,000
-23.3%
18,589
+7.6%
0.00%
-50.0%
Q3 2017$434,000
+11.3%
17,274
+6.7%
0.00%0.0%
Q2 2017$390,000
+42.9%
16,191
+14.1%
0.00%
+33.3%
Q1 2017$273,000
-1.1%
14,186
-20.7%
0.00%0.0%
Q4 2016$276,00017,8910.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders